Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AiCuris Anti-infective Cures GmbH

http://www.aicuris.com/

Latest From AiCuris Anti-infective Cures GmbH

European COVID-19 Project An ‘Unprecedented’ Exercise In Cooperation

Repurposed drugs, new compounds and neutralizing antibodies are among the targets of a new collaborative venture supported by Europe’s Innovative Medicines Initiative. 

Europe China

Coronavirus Update: Sanofi and GSK ‘Happy To Lose’ COVID-19 Vaccine Race

Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”

Coronavirus COVID-19 Companies

Royalty Pharma Nears Biopharma Record Take With $2.18bn IPO

Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.

Financing Business Strategies

Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo

Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.

Deals Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
UsernamePublicRestriction

Register